GlassScriptPhysician profile
Vanessa Frans
NPI 1184301806
$435.88
in general payments reported to CMS, 2019-2025
12 companies · $282 in 2025
The $282 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $154 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $435.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $87.67 | 2024-2025 | |
| Biogen, INC. | $59.47 | 2025 | Zurzuvae |
| Optumhealth Care Solutions, LLC | $55.28 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Sumitomo Pharma America, INC. | $45.44 | 2024-2025 | Gemtesa, Myfembree |
| Mayne Pharma Commercial LLC | $45.25 | 2025 | |
| Astellas Pharma US INC | $41.69 | 2025 | Veozah |
| Atricure, INC. | $24.07 | 2024 | |
| Heron Therapeutics, INC. | $20.19 | 2024 | Zynrelef |
| Pfizer INC. | $16.55 | 2024 | |
| Abbvie INC. | $15.68 | 2025 | |
| Exact Sciences Corporation | $15.25 | 2025 | Cologuard Collection Kit |
| Evofem Biosciences, INC. | $9.34 | 2025 | Phexxi, Solosec, Phexx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vanessa Frans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.